Schedule 13G ownership disclosure
aTYR PHARMA INC
Security class unavailable · CUSIP: 002120103
Event date: 2021-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,615,000
- Percent of class
- 10.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-21-000448
- Form type
- SC 13G
- Filer
- FEDERATED HERMES, INC.
- CIK
- CIK 1056288
- Filed
- Apr 09, 2021
- Reporting period
- Mar 31, 2021
- Description
- Schedule 13G beneficial ownership